Pure Global

"100 first" insulin radioimmunoassay reagents - Taiwan Registration a7fc296ff3bd73f2dda31ebc0f26ca8a

Access comprehensive regulatory information for "100 first" insulin radioimmunoassay reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a7fc296ff3bd73f2dda31ebc0f26ca8a and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
a7fc296ff3bd73f2dda31ebc0f26ca8a
Registration Details
Taiwan FDA Registration: a7fc296ff3bd73f2dda31ebc0f26ca8a
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"100 first" insulin radioimmunoassay reagents
TW: โ€œ็™พ้ฆ–โ€ ่ƒฐๅณถ็ด ๆ”พๅฐ„ๅ…็–ซๅˆ†ๆž่ฉฆๅŠ‘
Risk Class 2

Registration Details

a7fc296ff3bd73f2dda31ebc0f26ca8a

DHAS0602083202

Company Information

Belgium

Product Details

Insulin (INS) radioimmunoassay reagent for in vitro quantitative detection of human serum.

A Clinical chemistry and clinical toxicology

A.1405 Immune Response Insulin Test System

Imports must be accompanied by a letter of consent (a certificate of approval of the Atomic Energy Commission shall be attached to each batch of imports); input

Dates and Status

Feb 26, 2010

Feb 26, 2025